145 related articles for article (PubMed ID: 24928074)
1. Neurolymphomatosis: a case series of clinical manifestations, treatments, and outcomes.
Kamiya-Matsuoka C; Shroff S; Gildersleeve K; Hormozdi B; Manning JT; Woodman KH
J Neurol Sci; 2014 Aug; 343(1-2):144-8. PubMed ID: 24928074
[TBL] [Abstract][Full Text] [Related]
2. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes.
Jeong J; Kim SW; Sung DH
J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033
[TBL] [Abstract][Full Text] [Related]
3. Neurolymphomatosis: MRI and (18) FDG-PET features.
Lim AT; Clucas D; Khoo C; Parameswaran BK; Lau E
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):92-5. PubMed ID: 25974748
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features of neuropathy associated with lymphoma.
Tomita M; Koike H; Kawagashira Y; Iijima M; Adachi H; Taguchi J; Abe T; Sako K; Tsuji Y; Nakagawa M; Kanda F; Takeda F; Sugawara M; Toyoshima I; Asano N; Sobue G
Brain; 2013 Aug; 136(Pt 8):2563-78. PubMed ID: 23884813
[TBL] [Abstract][Full Text] [Related]
5. Neurolymphomatosis of the Brachial Plexus and its Branches: Case Series and Literature Review.
Bourque PR; Warman Chardon J; Bryanton M; Toupin M; Burns BF; Torres C
Can J Neurol Sci; 2018 Mar; 45(2):137-143. PubMed ID: 29307326
[TBL] [Abstract][Full Text] [Related]
6. Splenic marginal zone lymphoma: An indolent malignancy leading to the development of neurolymphomatosis.
Groth CL; Nevel KS; Gwathmey KG; Bafakih F; Jones DE
Muscle Nerve; 2017 Mar; 55(3):440-444. PubMed ID: 27625159
[TBL] [Abstract][Full Text] [Related]
7. Patient With 2 Hematologic Malignancies Presenting as Neurolymphomatosis.
Daher A; Kamiya-Matsuoka C; Woodman K
J Clin Neuromuscul Dis; 2018 Mar; 19(3):124-130. PubMed ID: 29465612
[TBL] [Abstract][Full Text] [Related]
8. High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma.
Matsue K; Hayama BY; Iwama K; Koyama T; Fujiwara H; Yamakura M; Takeuchi M; O'uchi T
Cancer; 2011 Oct; 117(19):4512-21. PubMed ID: 21448935
[TBL] [Abstract][Full Text] [Related]
9. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes.
Davidson T; Kedmi M; Avigdor A; Komisar O; Chikman B; Lidar M; Goshen E; Tzila Zwas S; Ben-Haim S
Leuk Lymphoma; 2018 Feb; 59(2):348-356. PubMed ID: 28750592
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of secondary peripheral neurolymphomatosis: a multi-center experience.
Byun JM; Kim KH; Kim M; Kim TM; Jeon YK; Park JH; Paik JH; Lee JM; Lee HY; Lee JS; Heo DS; Lee JO
Leuk Lymphoma; 2017 Nov; 58(11):2624-2632. PubMed ID: 28482727
[TBL] [Abstract][Full Text] [Related]
11. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M
Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723
[TBL] [Abstract][Full Text] [Related]
12. Neurolymphomatosis in non-Hodgkin lymphoma with cranial multineuritis: A case report.
Haydaroglu Sahin H; Mete A; Pehlivan M
Medicine (Baltimore); 2018 Apr; 97(15):e0303. PubMed ID: 29642156
[TBL] [Abstract][Full Text] [Related]
13. FDG PET to Diagnose Neurolymphomatosis in a Case of Triple-Hit B-Cell Lymphoma.
Bund C; Heimburger C; Trensz P; Fohrer C; Kremer S; Namer IJ
Clin Nucl Med; 2017 Jun; 42(6):458-460. PubMed ID: 28240665
[TBL] [Abstract][Full Text] [Related]
14. The Diagnostic Dilemma of Neurolymphomatosis.
Shree R; Goyal MK; Modi M; Gaspar BL; Radotra BD; Ahuja CK; Mittal BR; Prakash G
J Clin Neurol; 2016 Jul; 12(3):274-81. PubMed ID: 27449910
[TBL] [Abstract][Full Text] [Related]
15. Neurolymphomatosis of the peripheral nervous system: a case report and review of the literature.
Sideras PA; Matthews J; Sakib SM; Ofikwu F; Spektor V
Clin Imaging; 2016; 40(6):1253-1256. PubMed ID: 27636384
[TBL] [Abstract][Full Text] [Related]
16. Assessment of neurolymphomatosis by brachial plexus biopsy and PET/CT. Report of a case.
Bokstein F; Goor O; Shihman B; Rochkind S; Even-Sapir E; Metser U; Neufeld M
J Neurooncol; 2005 Apr; 72(2):163-7. PubMed ID: 15925997
[TBL] [Abstract][Full Text] [Related]
17. Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
Lin M; Kilanowska J; Taper J; Chu J
Hematol Oncol; 2008 Mar; 26(1):43-5. PubMed ID: 17957824
[TBL] [Abstract][Full Text] [Related]
18. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report.
Grisariu S; Avni B; Batchelor TT; van den Bent MJ; Bokstein F; Schiff D; Kuittinen O; Chamberlain MC; Roth P; Nemets A; Shalom E; Ben-Yehuda D; Siegal T;
Blood; 2010 Jun; 115(24):5005-11. PubMed ID: 20368468
[TBL] [Abstract][Full Text] [Related]
19. High-grade B-cell lymphoma relapse presenting as neurolymphomatosis of the median nerve.
Tai R; Maingard J; Nambiar M; Lim K
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30846458
[TBL] [Abstract][Full Text] [Related]
20. F-18 FDG PET/CT findings of a case of sacral nerve root neurolymphomatosis that occurred during chemotherapy.
Suga K; Yasuhiko K; Matsunaga N; Yujiri T; Nakazora T; Ariyoshi K
Clin Nucl Med; 2011 Jan; 36(1):73-6. PubMed ID: 21157220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
